@article{JTD2166,
author = {Daniel R. Gomez and Joe Y. Chang},
title = {Accelerated dose escalation with proton beam therapy for non-small cell lung cancer},
journal = {Journal of Thoracic Disease},
volume = {6},
number = {4},
year = {2014},
keywords = {},
abstract = {Local tumor control remains challenging in many cases of non-small cell lung cancer (NSCLC), particularly those that involve large or centrally located tumors. Concurrent chemotherapy and radiation can maximize tumor control and survival for patients with locally advanced disease, but a substantial proportion of such patients cannot tolerate this therapy, and sequential chemoradiation regimens or radiation given alone at conventionally fractionated doses produces suboptimal results. An alternative approach is the use of hypofractionated proton beam therapy (PBT). The energy distribution of protons can be exploited to reduce involuntary irradiation of normal tissues, particularly the low-dose irradiation problematic in intensity-modulated (photon) radiation therapy (IMRT). Here we summarize current evidence on the use of hypofractionated PBT for both early-stage and locally advanced NSCLC, and the possibility of using hypofractionated regimens for patients who are not candidates for concurrent chemotherapy.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/2166}
}